财经早报：7月3日

Group 1: Market and Economic Indicators - In June, the A-share market saw 1.65 million new accounts opened, bringing the total for the first half of the year to 12.6 million, a year-on-year increase of 32.77% compared to 9.49 million in the same period of 2024 [1] - The logistics industry in China reported a logistics prosperity index of 50.8% in June, up 0.2 percentage points from the previous month, indicating continued expansion in logistics business volume [1] - The Shanghai real estate market showed signs of recovery, with total transactions of new and second-hand housing reaching 1.311 million square meters in the first half of the year, a 17% increase year-on-year [1] Group 2: Company Announcements - Lixun Precision plans to issue shares overseas (H-shares) and list on the Hong Kong Stock Exchange [4] - Nanjing Shanglv expects a net profit decline of 67% to 78% year-on-year for the first half of the year [4] - Kaimeteqi reports normal operating conditions with no undisclosed significant matters [4] - Chengbang Co. states that its subsidiary, Xincun Electronics, currently has a small business scale [4] - Changchun High-tech's subsidiary, Fuxin Qibai monoclonal antibody for injection, has been approved for market entry in China [4] - Ruikang Pharmaceutical's director and vice president Li Zhe has been placed under detention [4] - Yonghui Supermarket reports that JD Shimao has reduced its stake in the company by 1.26% during the reduction period [4] - Betta Pharmaceuticals received approval from the National Medical Products Administration for the market application of Tartrate Teriparatide Capsules [4] - Hainan Highway plans to acquire a 51% stake in Jiaokong Petrochemical, which is expected to constitute a major asset restructuring [4]